Stem cells are being developed for use as therapies for many diseases. They also have strong potential for use in drug discovery, finding applications in toxicology testing and understanding disease mechanisms for novel target identification. The potential for this research is huge, and companies need to arm themselves with essential scientific knowledge alongside the necessary business understanding in this field.

SMi's 2nd Annual Stem Cells conference brings together leading pharmaceutical companies and smaller biotechs working in regenerative medicine to discuss the scientific advances and future business opportunities offered by stem cell research. Don't miss your chance to network with the leaders in this field, and look towards the future of this rapidly expanding area of medicine.

Speakers include:
•Mr Lyndon da Cruz, Consultant Vitreo-Retinal Surgeon,Moorfields Eye Hospital
•Professor Marc Lalande, Professor & Chairman, Department of Genetics and Developmental Biology, University of Connecticut Stem Cell Institute
•Dr Huseyin Mehmet, Director, Exploratory Biomarkers, Merck Research Laboratories

Plus choose from TWO post conference workshops:

1) Practical steps and strategies on obtaining patent protection for stem cells in association with D Young & Co 17th February 2010, Crowne Plaza Hotel – St James, London (Full Day)
2) Establishing and managing stem cell alliances and collaborations in association with Partnering Excellence and Atelix 17th February 2010, Crowne Plaza Hotel – St James, London (Half Day)

For more information or to book your place please visit: http://www.smi-online.co.uk/2010stemcells14.asp

Alternatively please contact: Daniel Davies tel: +44 (0) 20 7827 6062 email: ddavies@smi-online.co.uk

For more information or to book your place please visit: http://www.smi-online.co.uk/2010stemcells14.asp Alternatively please contact: Daniel Davies tel: +44 (0) 20 7827 6062 email: ddavies@smi-online.co.uk